Boston Scientific Corp (BSX) is a publicly traded medical devices business based in the US. It opened the day at $38.46 after a previous close of $38.14. During the day the price has varied from a low of $38.2239 to a high of $39.415. The latest price was $39.13 (25 minute delay). Boston Scientific is listed on the NYSE and employs 41,000 staff. All prices are listed in US Dollars.
Best for
0% commission
Best for
Beginner investments
Best for
Mobile app
Best for
Referral bonus
Both exchange rates and share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.
| Platform | Platform fee | Min. initial deposit | Trading fee estimate | |
|---|---|---|---|---|
|
£0 | $10 | £3.63 £728.86 total |
Capital at risk |
|
£0 | £250 | £12.94 £738.17 total |
Capital at risk |
|
£0 | No minimum | £7.25 £732.49 total |
Capital at risk |
 |
£0 | £1 | £19.20 £744.44 total |
Capital at risk |
 |
£0 | £0.01 | £0.73 £725.96 total |
Capital at risk |
 |
£0 | £1 | £3.26 £728.50 total |
Capital at risk |
 |
£9.99 per month | No minimum | £18.87 £744.10 total |
Capital at risk |
 |
£0 | £50 | £3.63 £728.86 total |
Capital at risk |
 |
£36 per year | £20 | £18.57 £743.80 total |
Capital at risk |
Full comparison of share dealing platforms
Historical closes compared with the last close of $39.13
| 1 week (2022-09-22) | -0.43% |
|---|---|
| 1 month (2022-08-29) | -3.12% |
| 3 months (2022-06-29) | 3.52% |
| 6 months (2022-03-25) | -10.05% |
| 1 year (2021-09-29) | -10.85% |
|---|---|
| 2 years (2020-09-29) | 3.63% |
| 3 years (2019-09-27) | -2.93% |
| 5 years (2017-09-29) | 34.14% |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value.
Boston Scientific's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 68x. In other words, Boston Scientific shares trade at around 68x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
However, Boston Scientific's P/E ratio is best considered in relation to those of others within the medical devices industry or those of similar companies.
Boston Scientific's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.0142. A PEG ratio over 1 can be interpreted as meaning shares are overvalued at the current rate of growth, or may anticipate an acceleration in growth.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Boston Scientific's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
However, it's sensible to consider Boston Scientific's PEG ratio in relation to those of similar companies.
Boston Scientific's EBITDA (earnings before interest, taxes, depreciation and amortisation) is a whopping $3.2 billion (£3 billion).
The EBITDA is a measure of a Boston Scientific's overall financial performance and is widely used to measure a its profitability.
To put that into context you can compare it against similar companies.
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Boston Scientific.
Boston Scientific's total ESG risk: 29.23
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Boston Scientific's overall score of 29.23 (as at 01/01/2019) is nothing to write home about – landing it in it in the 57th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Boston Scientific is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
To gain some more context, you can compare Boston Scientific's total ESG risk score against those of similar companies.
Boston Scientific's environmental score: 1.51/100
Boston Scientific's social score: 12.87/100
Boston Scientific's governance score: 7.87/100
Boston Scientific's controversy score: 3/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. A high-profile company, Boston Scientific scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that Boston Scientific hasn't always managed to keep its nose clean.
Wondering how that compares? Below are the controversy scores of similar companies.
Boston Scientific Corp was last rated for ESG on: 2019-01-01.
| Total ESG score | 29.23 |
|---|---|
| Total ESG percentile | 56.94 |
| Environmental score | 1.51 |
| Social score | 12.87 |
| Governance score | 7.87 |
| Level of controversy | 3 |
| Open | $38.46 |
|---|---|
| High | $39.415 |
| Low | $38.2239 |
| Close | $39.13 |
| Previous close | $38.14 |
| Change | $0.99 |
| Change % | 2.5957% |
| Volume | 6,483,311 |
| 52-week range | $34.98 - $47.5 |
|---|---|
| 50-day moving average | $40.7346 |
| 200-day moving average | $41.4643 |
| Wall St. target price | $48.49 |
| PE ratio | 68.2456 |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $0.57 |
We're not expecting Boston Scientific to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.
You may also wish to consider:
Over the last 12 months, Boston Scientific's shares have ranged in value from as little as $34.98 up to $47.5. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Boston Scientific's is 0.8466. This would suggest that Boston Scientific's shares are less volatile than average (for this exchange).
To put Boston Scientific's beta into context you can compare it against those of similar companies.
Ever wondered how to buy shares in Veru? We explain how and compare a range of providers that can give you access to many brands, including Veru.
Ever wondered how to buy shares in C4 Therapeutics? We explain how and compare a range of providers that can give you access to many brands, including C4 Therapeutics.
Ever wondered how to buy shares in Clever Leaves? We explain how and compare a range of providers that can give you access to many brands, including Clever Leaves.
Mental health stocks can be rewarding, but there are risks involved that could impact your profits. Find out how to invest in companies in the mental health industry.
Pharma stocks can be rewarding, but there are risks involved that could impact your profits. Find out the best way to invest in pharma stock.
Ever wondered how to buy shares in Bone Biologics? We explain how and compare a range of providers that can give you access to many brands, including Bone Biologics.
Ever wondered how to buy shares in Adagio Therapeutics? We explain how and compare a range of providers that can give you access to many brands, including Adagio.
Ever wondered how to buy shares in Bolt Biotherapeutics? We explain how and compare a range of providers that can give you access to many brands, including Bolt Biotherapeutics.
Ever wondered how to buy shares in Vallon Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Vallon Pharmaceuticals.
Ever wondered how to buy shares in Qualigen Therapeutics? We explain how and compare a range of providers that can give you access to many brands, including Qualigen.
